Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by DAVIES, D. R.
Right arrow Articles by DOUGHTY, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DAVIES, D. R.
Right arrow Articles by DOUGHTY, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 1967, Vol. 39, No. 8 638-644
© 1967 The Board of Management and Trustees of the British Journal of Anaesthesia

other

PREMEDICATION OF CHILDREN WITH PAPAVERETUM-HYOSCINE

The Effect of Varying Dosage Schemes

D. R. DAVIES and ANDREW DOUGHTY

Department of Anaesthetics, Kingston Group of Hospitals England

Papaveretum-hyoscine is a popular premedication for children but there is no agreement as to dosage. Four dosage schemes were compared in a double blind trial on children undergoing adenotonsillectomy in an attempt to determine the optimum method of using the drug mixture. No real difference in behaviour and co-operation in the anaesthetic room could be detected between any of the dosage schemes. The highest dosage is associated with excessive salivary suppression, increase in violent restlessness, postoperative vomiting and respiratory depression. One instance is reported of a near fatality due to respiratory depression following the postoperative opiate. The only advantage of the highest dosage is some increase of amnesia for the intravenous induction. For these reasons the lowest of the four dosage schemes used in the trial is recommended, namely, 2 mg/stone of papaveretum (with 0.04 mg/stone of hyoscine). This can be regarded as the normal adult dose scaled down in proportion to the weight of the child, and there is little justification for the use of stronger dosages as premedication for children.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.